You need to do an animal trial before you can do a human trial.
Upon a successful trial those results form the basis of an application for “in human” trials under the emergency use authorization (EUA) pathway provided by the FDA. And according to the announcement on Tuesday we are potentially going to know those results within 4 to 6 weeks!
If that goes to plan that will seriously move the share price and I mean significantly.
As glitterati pointed out the market for ARDS is enormous without COVID. Basically every death relating to Pneumonia is ARDS related, septicemia, septic shock, tetanus, kidney disease, UTI’s - all of these in extreme circumstances can bring on ARDS. And there currently is NO CURE GLOBALLY.
I really think this program is being underestimated.
Bring on the positive results!
Ted
IHL Price at posting:
5.1¢ Sentiment: Buy Disclosure: Held
